Trials / Completed
CompletedNCT04985682
A Study of ADVATE in People With Hemophilia A in India
Phase 4, Multicenter, Prospective, Interventional, Post-Marketing Study in Hemophilia A Patients in India Receiving ADVATE as On-Demand or Prophylaxis Under Standard Clinical Practice
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main aim of this study is to learn more about side effects of Advate when given as standard treatment to people with hemophilia A who have already been treated. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study. Participants will need to visit the study doctor 5 times in total during the study. During these visits, study data will be collected by the study doctor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ADVATE | Antihemophilic factor (AHF) activity expressed in international units (IU) per vial. |
Timeline
- Start date
- 2022-01-14
- Primary completion
- 2023-02-10
- Completion
- 2023-02-10
- First posted
- 2021-08-02
- Last updated
- 2024-03-07
- Results posted
- 2024-03-07
Locations
5 sites across 1 country: India
Source: ClinicalTrials.gov record NCT04985682. Inclusion in this directory is not an endorsement.